Formulation, preparation of niosome loaded zinc oxide nanoparticles and biological activities.

Hossein Rezaei, Alireza Iranbakhsh, Abbas Akhavan Sepahi, Amir Mirzaie, Kambiz Larijani
Author Information
  1. Hossein Rezaei: Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
  2. Alireza Iranbakhsh: Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran. iranbakhsh@iau.ac.ir.
  3. Abbas Akhavan Sepahi: Department of Microbiology, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran.
  4. Amir Mirzaie: Department of Biology, Parand Branch, Islamic Azad University, Parand, Iran.
  5. Kambiz Larijani: Department of Chemistry, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Abstract

In this study, zinc oxide nanoparticles (Zn-NPs) were prepared by the green synthesis method and loaded inside niosomes as a drug release system and their physicochemical and biological properties were determined. Zn-NPs were prepared by the eco-friendly green strategy, the structure, and morphological properties were studied and loaded into niosomes. Subsequently, different formulations of niosomes containing Zn-NPs were prepared and the optimal formulation was used for biological studies. Scanning electron microscope (SEM) and dynamic light scattering (DLS) were used to investigate the morphology and size of nanoparticles. Fourier transform infrared spectroscopy (FTIR) and UV-Vis were used to confirm the synthesis of Zn-NPs. Energy dispersive X-ray spectrometer (EDS) determined the elemental analysis of the Zn-NPs synthesis solution and the crystalline structure of Zn-NPs was analysed by XRD (X-Ray diffraction). Furthermore, Zn-NPs were loaded inside the niosomes, and their structural characteristics, entrapment efficiency (EE%), the release profile of Zn-NPs, and their stability also were assessed. Moreover, its antimicrobial properties against some microbial pathogens, its effect on the expression of biofilm genes, and its anticancer activity on the breast cancer cell lines were also determined. To study the cytocompatibility, exposure of niosomes against normal HEK-293 cells was carried out. In addition, the impact of niosomes on the expression of genes involved in the apoptosis (Bcl2, Casp3, Casp9, Bax) at the mRNA level was measured. Our findings revealed that the Zn-NPs have a round shape and an average size of 27.60 nm. Meanwhile, UV-Vis, FTIR, and XRD results confirmed the synthesis of Zn-NPs. Also, the EE% and the size of the optimized niosomal formulation were 31.26% and 256.6 ± 12 nm, respectively. The release profile showed that within 24 h, 26% of Zn-NPs were released from niosomes, while in the same period, 99% of free Zn-NPs were released, which indicates the slow release of Zn-NPs from niosomes. Antimicrobial effects exhibited that niosomes containing Zn-NPs had more significant antimicrobial and anti-biofilm effects than Zn-NPs alone, the antimicrobial and anti-biofilm effects increased 2 to 4 times. Cytotoxic effects indicated that when Zn-NPs are loaded into niosomes, the anticancer activity increases compared to Zn-NPs alone and has low cytotoxicity on cancer cells. Niosomes containing ZnNPs increased the apoptosis-related gene expression level and reduced the Bcl2 genes. In general, the results show that niosomes can increase the biological effects of free Zn-NPs and therefore can be a suitable carrier for targeted delivery of Zn-NPs.

Keywords

References

  1. Heliyon. 2023 Jul 26;9(8):e18710 [PMID: 37593605]
  2. Molecules. 2022 Oct 13;27(20): [PMID: 36296460]
  3. Saudi J Biol Sci. 2021 Mar;28(3):1808-1815 [PMID: 33732066]
  4. Sci Rep. 2022 Dec 19;12(1):21938 [PMID: 36536030]
  5. Front Chem. 2023 Mar 23;11:1138333 [PMID: 37035110]
  6. Plants (Basel). 2023 Jan 12;12(2): [PMID: 36679076]
  7. J Adv Periodontol Implant Dent. 2023 Jun 03;15(1):28-34 [PMID: 37645553]
  8. Anticancer Agents Med Chem. 2021;21(3):316-326 [PMID: 32698752]
  9. Bioprocess Biosyst Eng. 2023 Nov;46(11):1569-1578 [PMID: 37700115]
  10. Iran J Pharm Res. 2023 Feb 26;21(1):e134190 [PMID: 36896322]
  11. World J Microbiol Biotechnol. 2022 Oct 3;38(12):230 [PMID: 36184645]
  12. Sci Rep. 2021 Oct 25;11(1):20988 [PMID: 34697404]
  13. Naunyn Schmiedebergs Arch Pharmacol. 2023 Sep;396(9):2127-2136 [PMID: 36941384]
  14. Nanomaterials (Basel). 2019 Aug 17;9(8): [PMID: 31426465]
  15. Eur J Pharm Sci. 2022 Jan 1;168:106052 [PMID: 34740786]
  16. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jul-Aug;15(4):e1891 [PMID: 37032602]
  17. J Toxicol Environ Health B Crit Rev. 2017;20(3):155-182 [PMID: 28509652]
  18. Front Microbiol. 2023 Nov 30;14:1277533 [PMID: 38098658]
  19. Saudi J Biol Sci. 2022 Apr;29(4):2270-2279 [PMID: 35531172]
  20. Chemosphere. 2023 May;323:138263 [PMID: 36858116]
  21. Iran J Basic Med Sci. 2017 Apr;20(4):451-456 [PMID: 28804616]
  22. Microbiol Spectr. 2023 Feb 28;:e0483122 [PMID: 36853055]
  23. Photodiagnosis Photodyn Ther. 2021 Dec;36:102479 [PMID: 34375774]
  24. Materials (Basel). 2023 Apr 01;16(7): [PMID: 37049112]
  25. Cureus. 2023 Oct 23;15(10):e47535 [PMID: 38021724]
  26. Med Oncol. 2023 Feb 1;40(3):87 [PMID: 36723692]
  27. Front Bioeng Biotechnol. 2021 Oct 27;9:745099 [PMID: 34778226]
  28. Int J Pharm. 2023 Mar 25;635:122715 [PMID: 36773728]
  29. Nanotechnology. 2020 May 8;31(19):195101 [PMID: 31958777]
  30. Daru. 2019 Jun;27(1):329-339 [PMID: 31134490]
  31. Curr Drug Deliv. 2018 Feb 14;15(2):260-266 [PMID: 28521674]
  32. Drug Deliv Transl Res. 2024 Apr;14(4):1077-1092 [PMID: 37957473]
  33. Int J Nanomedicine. 2020 Nov 11;15:8767-8781 [PMID: 33204087]
  34. ACS Appl Nano Mater. 2023 Sep 11;6(18):17149-17160 [PMID: 37772266]
  35. Pharm Dev Technol. 2023 Sep;28(7):708-718 [PMID: 37448342]
  36. Cancer Res. 2022 Jul 18;82(14):2503-2514 [PMID: 35584245]
  37. J Photochem Photobiol B. 2020 Jan;202:111644 [PMID: 31770706]
  38. Mater Today Bio. 2023 Oct 21;23:100837 [PMID: 37953758]
  39. Eur J Pharm Biopharm. 2019 Nov;144:18-39 [PMID: 31446046]
  40. Int J Biol Macromol. 2023 Jun 30;241:124651 [PMID: 37119885]
  41. Biol Trace Elem Res. 2024 May;202(5):1878-1900 [PMID: 37639166]
  42. Nanomaterials (Basel). 2023 Aug 24;13(17): [PMID: 37686914]
  43. Photodiagnosis Photodyn Ther. 2023 Mar;41:103288 [PMID: 36640857]
  44. Artif Cells Nanomed Biotechnol. 2023 Dec;51(1):604-617 [PMID: 37910394]

MeSH Term

Humans
Zinc Oxide
Liposomes
Metal Nanoparticles
Antineoplastic Agents
Biofilms
Particle Size
Cell Line, Tumor
MCF-7 Cells
Apoptosis
HEK293 Cells
Spectroscopy, Fourier Transform Infrared
Cell Survival
Drug Compounding

Chemicals

Zinc Oxide
Liposomes
Antineoplastic Agents

Word Cloud

Created with Highcharts 10.0.0Zn-NPsniosomesloadedsynthesiseffectsnanoparticlesreleasebiologicaloxidepreparedpropertiesdeterminedcontainingusedsizeantimicrobialexpressiongenesstudyzincgreenmethodinsidestructureformulationFTIRUV-VisXRDEE%profilealsoanticanceractivitycancercellsBcl2levelresults26%releasedfreeanti-biofilmaloneincreasedcanactivitiesNiosomedrugsystemphysicochemicaleco-friendlystrategymorphologicalstudiedSubsequentlydifferentformulationsoptimalstudiesScanningelectronmicroscopeSEMdynamiclightscatteringDLSinvestigatemorphologyFouriertransforminfraredspectroscopyconfirmEnergydispersiveX-rayspectrometerEDSelementalanalysissolutioncrystallineanalysedX-RaydiffractionFurthermorestructuralcharacteristicsentrapmentefficiencystabilityassessedMoreovermicrobialpathogenseffectbiofilmbreastcelllinescytocompatibilityexposurenormalHEK-293carriedadditionimpactinvolvedapoptosisCasp3Casp9BaxmRNAmeasuredfindingsrevealedroundshapeaverage2760 nmMeanwhileconfirmedAlsooptimizedniosomal312566 ± 12 nmrespectivelyshowedwithin24 hperiod99%indicatesslowAntimicrobialexhibitedsignificant24timesCytotoxicindicatedincreasescomparedlowcytotoxicityNiosomesZnNPsapoptosis-relatedgenereducedgeneralshowincreasethereforesuitablecarriertargeteddeliveryFormulationpreparationniosomeBiologicalGreenZinc

Similar Articles

Cited By (3)